Boron- and phosphorus-containing molecular/nano platforms: exploiting pathological redox imbalance to fight cancer

Area of Science:

• Oncology
• Materials Science
• Medicinal Chemistry

Background:

• Cancer remains a leading global cause of death with persistent challenges in treatment efficacy and high recurrence rates.
• Redox imbalance is a key characteristic of cancer cells that presents a potential therapeutic target.
• Current anticancer therapies face limitations, necessitating the exploration of novel treatment modalities.

Purpose of the Study:

• To review recent advancements in boron- and phosphorus-containing materials for anticancer drug design.
• To highlight the potential of these materials in exploiting cancer cell redox imbalance.
• To provide insights into methodologies for developing targeted cancer therapies.

Main Methods:

• Review of recent literature on boron and phosphorus derivatives in cancer research.
• Analysis of the chemical properties and tuneability of boron and phosphorus compounds.
• Exploration of strategies for designing molecular and nano-platforms targeting cancer redox imbalance.

Main Results:

• Boron and phosphorus derivatives offer unique chemical properties for drug design, including regioselectivity, tuneability, and stability.
• These materials can be engineered into platforms to selectively target cancer cell redox imbalance, inducing necrosis or apoptosis.
• The field is nascent but shows significant promise for developing novel anticancer agents.

Conclusions:

• Boron- and phosphorus-based molecular/nano platforms represent a promising avenue for rational anticancer drug discovery.
• Targeting cancer's redox imbalance with these materials offers a selective approach to treatment.
• Further research and development in this area hold substantial potential for improving cancer therapy outcomes.